Yes, Democrats Are Even Anti-Nice Meals for Our Troops
Huh? Dems Are Going to Try and Hurt Trump Over This?
Are We Shocked the Polling on the Iran Airstrikes Shifts Dramatically When This...
The Latest Update on the Suspected Old Dominion University Terror Attack Is Infuriating
US Officials Warn That Iran Is Opening Up a New Front In the...
Woman Launches GoFundMe to Help Her DoorDash Driver Finally Retire
Gavin Newsom's Early Release Law Just Set Criminal With 300-Year Sentence Free
Secretary Hegseth Provided an Update on Operation Epic Fury. Here's What He Said.
Here's More Proof Mamdani's Wife Has an Antisemitism Problem
Is Buzzfeed About to Go Bust?
CENTCOM Confirms Four Heroes Killed in Refueling Aircraft Crash
The State of American Conservation Is Strong at SCI Convention
Democrats Side With the Mullahs
Trump Is Right: The Save America Act Is Crucial
TrumpRx Is a Step Toward Making the Pharma Market Finally Work for America
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement